US › Healthcare

InfuSystems Holdings Inc (INFU)

US · Healthcare · Medical Devices

$13.40-3.74%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$36.9M

Revenue YoY

+2.6%

Net profit

$3.2M

Profit YoY

+24.3%

EPS

$0.15

EPS estimate

$0.12

Net margin

8.7%

EPS came in at 0.15 against a street estimate of 0.12 — a beat of 25.0%.

Key statistics

Market cap

$270.1M

P/E

33.9

Forward P/E

22.7

P/B

4.28

Book value

$2.97

EPS (TTM)

$0.40

52-week high

$13.85

52-week low

$7.29

50-day MA

$12.26

200-day MA

$9.92

Beta

1.49

Analyst view

Analysts rate InfuSystems Holdings Inc a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $16.83.

Shareholding

Insiders

7.24%

Institutions

84.68%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for InfuSystems Holdings Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.